Spyre Therapeutics, Inc. (SYRE)
40.57
-1.92
(-4.52%)
USD |
NASDAQ |
Mar 03, 12:10
Spyre Therapeutics EPS Diluted (Quarterly) : -0.6903 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | -0.5006 |
| PTC Therapeutics, Inc. | -1.673 |
| Agios Pharmaceuticals, Inc. | -1.852 |
| Tandem Diabetes Care, Inc. | -0.0087 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.83M |
| Total Expenses (Quarterly) | 51.83M |
| Enterprise Value | 2.736B |
| Earnings Yield | -5.12% |
| Normalized Earnings Yield | -5.351 |